Higher Blood Vascular Cell Adhesion Molecule-1 is Related to the Increased Risk of Cardiovascular Events in Chronic Obstructive Pulmonary Disease

References

• YangIA, BrownJL, JohnsonG, et al. COPD-X Australian and New Zealand guidelines for the diagnosis and management of chronic obstructive pulmonary disease: 2017 update. Medical J Australia. 2017;207(10):436–442. doi:10.5694/mja17.00686
   PubMed Web of Science ®Google Scholar
• Vogelmeier CF, Criner GJ, Martinez FJ, et al. Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Lung Disease 2017 Report. GOLD Executive Summary. Am J Respir Crit Care Med. 2017;195(5):557–582.
   Google Scholar
• LeitaoFF, SinDD. COPD and cardiovascular diseases: now is the time for action. Thorax. 2018;73(9):799–800. doi:10.1136/thoraxjnl-2018-21155329622696
   PubMed Web of Science ®Google Scholar
• SchneiderC, BothnerU, S SJ, et al. Chronic obstructive pulmonary disease and the risk of cardiovascular diseases. Eur J Epidemiol. 2010;25(4):253–260. doi:10.1007/s10654-010-9435-720191376
   PubMed Web of Science ®Google Scholar
• BarnesPJ. Senescence in COPD and its Comorbidities. Annu Rev Physiol. 2017;79(1):517. doi:10.1146/annurev-physiol-022516-03431427959617
   PubMed Web of Science ®Google Scholar
• KumarAG, DaiXY, KozakCA, et al. Murine VCAM-1. Molecular cloning, mapping, and analysis of a truncated form. J Immunol. 1994;153:4088–4098.7523515
   PubMed Web of Science ®Google Scholar
• OsbornL, HessionC, TizardR, et al. Direct expression cloning of vascular cell adhesion molecule 1, a cytokine-induced endothelial protein that binds to lymphocytes. Cell. 1989;59:1203–1211. doi:10.1016/0092-8674(89)90775-72688898
   PubMed Web of Science ®Google Scholar
• Willeit K, Pechlaner R, Willeit P, et al. Association Between Vascular Cell Adhesion Molecule 1 and Atrial Fibrillation. JAMA Cardiol. 2017;2(5):516–523.
   Google Scholar
• KaufmannBA, SandersJM, DavisC, et al. Molecular imaging of inflammation in atherosclerosis with targeted ultrasound detection of vascular cell adhesion molecule-1. Circulation. 2007;116(3):276–284. doi:10.1161/CIRCULATIONAHA.106.68473817592078
   PubMed Web of Science ®Google Scholar
• NankangH, Kevin, et al. N0X2 in lung inflammation: quantum dot based in situ imaging of NOX2-mediated expression of vascular cell adhesion molecule-1. Am J Physiol. 2014.
   Google Scholar
• ChoYS, KimCH, HaTS, et al. Inhibition of STAT3 phosphorylation by sulforaphane reduces adhesion molecule expression in vascular endothelial cell. Can J Physiol Pharmacol. 2016;94(11):1. doi:10.1139/cjpp-2015-015026640164
   PubMed Web of Science ®Google Scholar
• LemosJAD, HennekensCH, RidkerPM. Plasma concentration of soluble vascular cell adhesion molecule-1 and subsequent cardiovascular risk. J Am Coll Cardiol. 2000;36(2):423–426. doi:10.1016/S0735-1097(00)00742-710933352
   PubMed Web of Science ®Google Scholar
• PapiA, BellettatoCM, BraccioniF, et al. Infections and airway inflammation in chronic obstructive pulmonary disease severe exacerbations. Am J Respir Crit Care Med. 2006;173(10):1114–1121. doi:10.1164/rccm.200506-859OC16484677
   PubMed Web of Science ®Google Scholar
• LeenaG, Christopher, et al. Eosinophilic airway inflammation: role in asthma and chronic obstructive pulmonary disease. Ther Adv Chronic Dis. 2016.
   Web of Science ®Google Scholar
• GibbonsM, SethiT. Chronic obstructive pulmonary disease and lung cancer: inflammation, the missing link. Therapy. 2009;6(6):805–820. doi:10.2217/thy.09.77
   Google Scholar
• WilkinsonTMA, DonaldsonGC, JohnstonSL, et al. Respiratory syncytial virus, airway inflammation, and FEV 1 decline in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2006;173(8):871–876.16456141
   PubMed Web of Science ®Google Scholar
• AntuniJD, BarnesPJ. Evaluation of individuals at risk for COPD: beyond the scope of the global initiative for chronic obstructive lung disease. Chronic Obstr Pulm Dis. 2016;3(3):653–667.28848890
   PubMed Web of Science ®Google Scholar
• LeveyAS, StevensLA, SchmidCH, et al. A new equation to estimate glomerular filtration rate. Ann Intern Med. 2009;150(9):604–612.19414839
   PubMed Web of Science ®Google Scholar
• RoversiS, FabbriLM, D DS, et al. Chronic obstructive pulmonary disease and cardiac diseases: an urgent need for integrated care. Am J Respir Crit Care Med. 2016;rccm.201604–0690SO.
   PubMed Web of Science ®Google Scholar
• WangLY, ZhuYN, CuiJJ, et al. Subclinical atherosclerosis risk markers in patients with chronic obstructive pulmonary disease: A systematic review and meta-analysis. Respir Med. 2017;123:18–27. doi:10.1016/j.rmed.2016.12.00428137492
   PubMed Web of Science ®Google Scholar
• ZagacetaJ, BastarrikaG, ZuluetaJJ, et al. Prospective comparison of non-invasive risk markers of major cardiovascular events in COPD patients. Respir Res. 2017;18(1):175. doi:10.1186/s12931-017-0658-y28962654
   PubMed Web of Science ®Google Scholar
• TurgayS, DanielRS, JenniferN, et al. Epicardial fat, cardiovascular risk factors and calcifications in patients with chronic kidney disease. Clin Kidney J.
   Web of Science ®Google Scholar
• LahousseL, TiemeierH, IkramMA, et al. Chronic obstructive pulmonary disease and cerebrovascular disease: A comprehensive review. Respir Med. 2015;S0954611115300299.
   Google Scholar
• FitzGeraldJ, Mark. Risk of cardiovascular comorbidity in patients with chronic obstructive pulmonary disease: a systematic review and meta-analysis. Lancet Respir Med. 2015.
   PubMed Web of Science ®Google Scholar
• MorganAD, ZakeriR, QuintJK. Defining the relationship between COPD and CVD: what are the implications for clinical practice? Ther Adv Respir Dis. 2018;12:175346581775052. doi:10.1177/1753465817750524
   Web of Science ®Google Scholar
• SarahH-W, Rudolf, et al. Peripheral artery disease and its clinical relevance in patients with chronic obstructive pulmonary disease in the COPD and systemic consequences–comorbidities network study. Am J Respir Crit Care Med. 2017.
   Web of Science ®Google Scholar
• HopeSA, MeredithIT. Cellular adhesion molecules and cardiovascular disease; part I: their expression and role in atherogenesis. Intern Med J. 2003;33(8):380–386.12895171
   PubMed Web of Science ®Google Scholar
• BlankenbergS, BarbauxS, TiretL. Adhesion molecules and atherosclerosis. Atherosclerosis. 2003;170(2):191–203. doi:10.1016/S0021-9150(03)00097-214612198
   PubMed Web of Science ®Google Scholar
• ChenMC, ChangHW, JuangSS, et al. Percutaneous transluminal mitral valvuloplasty reduces circulating vascular cell adhesion molecule-1in rheumatic mitral stenosis. Chest. 2004;125(4):1213–1217. doi:10.1378/chest.125.4.121315078727
   PubMed Web of Science ®Google Scholar
• MalikI, DaneshJ, WhincupP, et al. Soluble adhesion molecules and prediction of coronary heart disease: a prospective study and meta-analysis. Lancet. 2001;358(9286):971–976. doi:10.1016/S0140-6736(01)06104-911583751
   PubMed Web of Science ®Google Scholar
• TsutamotoT, WadaA, MaedaK, et al. AngiotensinII type1 receptor antagonist decreases plasma levels of tumor necrosis factor alpha, interleukin-6 and soluble adhesion molecules in patients with chronic heart failure. J Am Coll Cardiol. 2000;35(3):714–721. doi:10.1016/S0735-1097(99)00594-X10716475
   PubMed Web of Science ®Google Scholar
• WilleitK, PechlanerR, WilleitP, et al. Association between vascular cell adhesion molecule 1 and atrial fibrillation. JAMA Cardiol. 2017;2:516. doi:10.1001/jamacardio.2017.006428355442
   PubMed Web of Science ®Google Scholar
• HugoV. Systemic vascular cell adhesion molecule-1 predicts the occurrence of post-operative atrial fibrillation. Int J Cardiol. 2011.
   Web of Science ®Google Scholar
• GoetteA, BukowskaA, LendeckelU, et al. AngiotensinII receptor blockade reduces tachycardia-induced atrial adhesion molecule expression. Circulation. 2008;117(6):732–742. doi:10.1161/CIRCULATIONAHA.107.73010118227384
   PubMed Web of Science ®Google Scholar
• HammwöhnerM, IttensonA, DierkesJ, et al. Platelet expression of CD40/CD40 ligand and its relation to inflammatory markers and adhesion molecules in patients with atrial fibrillation. ExpBiol Med. 2007;232(4):581–589.
   Google Scholar